HERON THERAPEUTICS, INC. /DE/ Debt Securities, Available-for-sale, Unrealized Gain (Loss)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$9.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2026-02-26
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, unrealized gain (loss) for fiscal 2025 was -$9.00K.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $32.00K.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was -$13.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$9.00K 10-K · filed 2026-02-26 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2023-12-31 | $32.00K 10-K · filed 2026-02-26 | |
| 2022-12-31 | -$13.00K 10-K · filed 2024-03-12 | |
| 2021-12-31 | -$263.00K 10-K · filed 2023-03-29 | -$300.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $200.00K 10-K · filed 2022-02-28 | $172.00K 10-K · filed 2021-02-24 |
| 2019-12-31 | $200.00K 10-K · filed 2022-02-28 | $172.00K 10-K · filed 2020-03-02 |
| 2018-12-31 | -$77.00K 10-K · filed 2021-02-24 | |
| 2017-12-31 | $7.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |